Skip to main content
. 2020 Jan 21;2020:8317973. doi: 10.1155/2020/8317973

Table 2.

Twenty-four-hour average glycemia and indices in healthy subjects at baseline, during, and after Gentle Jogger jogging device (JD).

BL JD2 JD3 JD4 JD5 JD6 JD7 Post JD1 Post JD2
mGlu (mg/dl) 92.7 82.4 84.4 83.6 83.3 82.8 81.0 85.9 85.24
SD 6.6 6.7 7.5 7.5 7.9 8.4 10.2 11.3 9.213
SUM (mg/dl) 8929 7932 8126 8046 8017 7968 7801 8262 8205
SD 632.7 642.1 705.5 708.3 748.1 789.4 979.6 1073 873.9
%CV 21.1 11.9 14.3 15.4 12.7 13.2 12.4 17.2 18.4
SD 7.7 3.4 5.3 6.7 3.3 5.8 4.3 5.6 5.2
AUC 1802 1630 1653 1733 1626 1666 1629 1723 1687
SD 236.2 164.3 193.7 185.3 156.5 180.9 228 234.1 254.2
% time in range (TIR, glucose 70-180 mg/dl)
Mean 93.8 93.6 94.2 95.9 96.5 93.0 87.9 93.6 91.1
SD 9.4 12.4 11.5 8.4 8.4 14.9 26 13.2 16.6
% time below range (TBR, glucose < 70 mg/dl)
Mean 5.2 5.4 6.9 6.5 5.9 5.7 11.1 7.7 9.2
SD 9.9 12.2 11.0 11.0 11.6 17.0 25.0 13.3 15.9

Values for twenty-four-hour mean glucose (mGlu, mg/dl), sum of 24 hr glucose (SUM mg/dl), coefficient of variation (%CV), and 24 hr area under the glucose curve (AUC), in healthy subjects. % time in range (TIR, glucose between 70 and 180 mg/dl, % time below range (TBR, glucose < 70 mg/dl). Data are expressed as the mean (SD, standard deviation). The time points are 24 hr prior to operation of JD (BL), after 2, 3, 4, 5, 6, and 7 days of JD (JD2, JD3, JD4, JD5, JD6, JD7), and 24 and 48 hr after discontinuation of JD (Post JD1, Post JD2). Statistical significance < p < 0.01 vs. BL.